GLIONOVA AB has a total of 12 patent applications. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are SHENZHEN NEPTUNUS PHARMACEUTICAL TECH RESEARCH COMPANY LIMITED, NANJING GRITPHARMA CO LTD and HANGZHOU EAST CHINA PHARMACEUTICAL GROUP NEW DRUG RES INSTITUTE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials | |
#5 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Hammarström Lars | 7 |
#2 | Gravenfors Ylva | 7 |
#3 | Ernfors Patrik | 7 |
#4 | Kitambi Satish | 7 |
#5 | Hammarstrom Lars | 3 |
#6 | Färnegårdh Katarina | 3 |
#7 | Farnegardh Katarina | 3 |
#8 | Larsson Ulf | 2 |
#9 | Svensson Per H | 2 |
#10 | Enfors Patrik | 2 |
Publication | Filing date | Title |
---|---|---|
EP3064205A1 | Therapeutic use of isomeric forms of 2-(4-chlorophenyl)quinolin-4-yl)(piperidin-2-yl)methanol | |
EP3064493A1 | Crystalline forms of (r)-(2-(4-chlorophenyl)quinolin-4-yl)((s)-(piperidin-2-yl)methanol | |
CN105873588A | Compounds and use for treating cancer |